EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Verbal fluency tests assess global cognitive status but have limited diagnostic differentiation: evidence from a large-scale examination of six neurodegenerative diseases

Shalom K Henderson iD, Katie A Peterson, Karalyn Patterson iD, Matthew A Lambon Ralph iD, James B Rowe

Brain Communications · 2023-03-02 · 5 (2)

DOI: 10.1093/braincomms/fcad042 ↗

At a glance

Journal article in Brain Communications, published online on 2023-02-21. Written by Shalom K Henderson and 4 co-authors. Institution: MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK. Cited 49 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, Medical Research Council, Bill & Melinda Gates Foundation.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Verbal fluency is widely used as a clinical test, but its utility in differentiating between neurodegenerative dementias and progressive aphasias, and from healthy controls, remains unclear. We assessed whether various measures of fluency performance could differentiate between Alzheimer’s disease, behavioural variant of frontotemporal dementia, non-fluent and semantic variants of primary progressive aphasia, progressive supranuclear palsy, corticobasal syndrome and healthy controls. Category and letter fluency tasks were administered to 33 controls and 139 patients at their baseline clinical visit. We assessed group differences for total number of words produced, psycholinguistic word properties and associations between production order and exemplar psycholinguistic properties. Receiver operating characteristic curves determined which measure could best discriminate patient groups and controls. The total word count distinguished controls from all patient groups, but neither this measure nor the word properties differentiated the patient groups. Receiver operating characteristic curves revealed that, when comparing controls to patients, the strongest discriminators were total word count followed by word frequency. Word frequency was the strongest discriminator for semantic variant of primary progressive aphasia versus other groups. Fluency word counts were associated with global severity as measured by Addenbrooke’s Cognitive Examination Revised. Verbal fluency is an efficient test for assessing global brain–cognitive health but has limited utility in differentiating between cognitively and anatomically disparate patient groups. This outcome is consistent with the fact that verbal fluency requires many different aspects of higher cognition and language.

Subjects

Author keywords

Alzheimer’s diseaseParkinson-plus disordersfrontotemporal dementiaprimary progressive aphasiaverbal fluency

Authors and institutions

  • MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK.
  • Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 7EF, UK.
  • Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 7EF, UK.

ORCID profiles: Shalom K Henderson, Karalyn Patterson, Matthew A Lambon Ralph

Funding

  • Wellcome Trust
  • Medical Research Council
  • Bill & Melinda Gates Foundation
  • Gates Cambridge Scholarship
  • Cambridge Centre for Parkinson-Plus
  • National Institute for Health and Care Research Cambridge Clinical Research Facility
  • National Institute for Health and Care Research Cambridge Biomedical Research Centre
  • MRC Cognition and Brain Sciences Unit

Cite

APA

Henderson, S. K., Peterson, K. A., Patterson, K., Lambon Ralph, M. A., & Rowe, J. B. (2023). Verbal fluency tests assess global cognitive status but have limited diagnostic differentiation: evidence from a large-scale examination of six neurodegenerative diseases. Brain Communications, 5(2). https://doi.org/10.1093/braincomms/fcad042

Vancouver

Henderson SK, Peterson KA, Patterson K, Lambon Ralph MA, Rowe JB. Verbal fluency tests assess global cognitive status but have limited diagnostic differentiation: evidence from a large-scale examination of six neurodegenerative diseases. Brain Communications. 2023;5(2). doi:10.1093/braincomms/fcad042

BibTeX
@article{Henderson2023,
  author = {Henderson, Shalom K and Peterson, Katie A and Patterson, Karalyn and Lambon Ralph, Matthew A and Rowe, James B},
  title = {Verbal fluency tests assess global cognitive status but have limited diagnostic differentiation: evidence from a large-scale examination of six neurodegenerative diseases},
  journal = {Brain Communications},
  year = {2023},
  volume = {5},
  number = {2},
  doi = {10.1093/braincomms/fcad042}
}
Start for free →